SMi’s Biosimilars & Biobetters Exclusive Interview with expert speaker Dr Michel Mikhail released Read more
FDA grants priority review to Merck’s sBLA for KEYTRUDA to treat advanced hepatocellular carcinoma Read more
Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies Read more
Genmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer Immunotherapies Read more